Shopping Cart 0
Cart Subtotal
USD 0

ICON Plc (ICLR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company's service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic, and software devices. The company offers research services in areas such as cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, nonalcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, women's health therapeutics and other therapeutic areas. ICON is headquartered in Dublin, Ireland.

ICON Plc (ICLR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10

ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

ICON Plc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To USD 56 Million 12

Venture Financing 13

Aptiv Solutions Raises USD 5.7 Million In Venture Financing 13

Merger 14

Inclinix Merges With PMG Research 14

Licensing Agreements 15

Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15

Debt Offering 16

ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16

Acquisition 17

ICON Acquires Mapi 17

Icon Acquires Clinical Research Management 18

Icon Acquires PMG Research from Frontier Capital 19

ICON Acquires MediMedia Pharma Solutions for USD120 Million 20

Icon Completes Acquisition Of Aptiv Solutions For USD 143.5 Million 21

Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23

ICON Plc-Key Competitors 24

ICON Plc-Key Employees 25

ICON Plc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 29

Strategy And Business Planning 29

Mar 29, 2018: ICON Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution 29

Mar 14, 2018: ICON opens a new office in Boston 30

Financial Announcements 31

Oct 24, 2018: ICON Reports Third Quarter 2018 Results 31

Oct 24, 2018: ICON reports third quarter 2018 results 33

Jul 25, 2018: ICON Reports Second Quarter 2018 Results 35

May 02, 2018: ICON Reports First Quarter 2018 Results 37

Feb 15, 2018: ICON Reports Fourth Quarter and Full Year 2017 Results 38

Jan 09, 2018: ICON Issues Financial Guidance for Full Year 2018 40

Oct 26, 2017: ICON Reports Third Quarter 2017 Results 41

Jul 27, 2017: ICON Reports Second Quarter 2017 Results 42

Apr 27, 2017: ICON Reports First Quarter 2017 Results 43

Feb 16, 2017: ICON Reports Fourth Quarter and Full Year 2016 Results 44

Jan 09, 2017: ICON Issues Financial Guidance for Full Year 2017 45

Corporate Communications 46

Jul 27, 2018: ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe 46

Jan 09, 2018: ICON Appoints Dr. James Cummings as President of ClinicalRM 47

Nov 17, 2017: ICON Announces Appointment of Ms. Joan Garahy to Board of Directors 48

Oct 04, 2017: ICON Announces Appointment of Mr. Eugene McCague to Board of Directors 49

Government and Public Interest 50

Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 50

Product News 52

Nov 21, 2017: ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening 52

Nov 07, 2017: ICON contributes to major European research study that aims to improve treatment for traumatic brain injury 53

Feb 20, 2017: ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials 54

Other Significant Developments 55

Oct 01, 2018: ICON announces release of ADDPLAN Neo 55

Jun 22, 2018: ICON and DIA driving Insights to Action with DIA Live 2018 56

Apr 03, 2018: ICON announces launch of Government and Public Health Solutions to support global public health 57

Nov 21, 2017: FIRECREST Pre-Screen improves sponsor visibility of patient access 58

Nov 06, 2017: ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress 59

Oct 27, 2017: ICON and ICHOM unveil the world's first global patient outcomes benchmarking platform 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

ICON Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ICON Plc, Deals By Therapy Area, 2012 to YTD 2018 9

ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10

ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To USD 56 Million 12

Aptiv Solutions Raises USD 5.7 Million In Venture Financing 13

Inclinix Merges With PMG Research 14

Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15

ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16

ICON Acquires Mapi 17

Icon Acquires Clinical Research Management 18

Icon Acquires PMG Research from Frontier Capital 19

ICON Acquires MediMedia Pharma Solutions for USD120 Million 20

Icon Completes Acquisition Of Aptiv Solutions For USD 143.5 Million 21

Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23

ICON Plc, Key Competitors 24

ICON Plc, Key Employees 25

ICON Plc, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

ICON Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

ICON plc (ICON) is a contract research organization (CRO) that provides outsourced development services to the biotechnology, pharmaceutical and medical device industries worldwide. It provides a range of specialized services that span the entire lifecycle of product development. The company's service portfolio includes adaptive trials, biosimilars, clinical research services, commercialization and outcomes, consulting, functional services provision, medical imaging, laboratory services, resourcing solutions and strategic support and tactical solutions for traditional, in vitro diagnostic, and software devices. The company offers research services in areas such as cancer, genomics, central nervous system, cardiovascular, endocrine and metabolic disorders, gastrointestinal, medical device, nonalcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, transplant and immunology, vaccines, women's health therapeutics and other therapeutic areas. ICON is headquartered in Dublin, Ireland.

ICON Plc (ICLR)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10

ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

ICON Plc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To USD 56 Million 12

Venture Financing 13

Aptiv Solutions Raises USD 5.7 Million In Venture Financing 13

Merger 14

Inclinix Merges With PMG Research 14

Licensing Agreements 15

Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15

Debt Offering 16

ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16

Acquisition 17

ICON Acquires Mapi 17

Icon Acquires Clinical Research Management 18

Icon Acquires PMG Research from Frontier Capital 19

ICON Acquires MediMedia Pharma Solutions for USD120 Million 20

Icon Completes Acquisition Of Aptiv Solutions For USD 143.5 Million 21

Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23

ICON Plc-Key Competitors 24

ICON Plc-Key Employees 25

ICON Plc-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 29

Strategy And Business Planning 29

Mar 29, 2018: ICON Helps Establish New Industry Standards Group to Improve Clinical Trial Collaboration and Execution 29

Mar 14, 2018: ICON opens a new office in Boston 30

Financial Announcements 31

Oct 24, 2018: ICON Reports Third Quarter 2018 Results 31

Oct 24, 2018: ICON reports third quarter 2018 results 33

Jul 25, 2018: ICON Reports Second Quarter 2018 Results 35

May 02, 2018: ICON Reports First Quarter 2018 Results 37

Feb 15, 2018: ICON Reports Fourth Quarter and Full Year 2017 Results 38

Jan 09, 2018: ICON Issues Financial Guidance for Full Year 2018 40

Oct 26, 2017: ICON Reports Third Quarter 2017 Results 41

Jul 27, 2017: ICON Reports Second Quarter 2017 Results 42

Apr 27, 2017: ICON Reports First Quarter 2017 Results 43

Feb 16, 2017: ICON Reports Fourth Quarter and Full Year 2016 Results 44

Jan 09, 2017: ICON Issues Financial Guidance for Full Year 2017 45

Corporate Communications 46

Jul 27, 2018: ICON Confirms Retirement of Co-Founder Dr. Ronan Lambe 46

Jan 09, 2018: ICON Appoints Dr. James Cummings as President of ClinicalRM 47

Nov 17, 2017: ICON Announces Appointment of Ms. Joan Garahy to Board of Directors 48

Oct 04, 2017: ICON Announces Appointment of Mr. Eugene McCague to Board of Directors 49

Government and Public Interest 50

Mar 27, 2018: Leading CROs Form New Industry Standards Group to Improve Collaboration with Sponsors 50

Product News 52

Nov 21, 2017: ICON Launches FIRECREST Pre-Screen to Improve the Speed and Accuracy of Identifying Eligible Patients for Screening 52

Nov 07, 2017: ICON contributes to major European research study that aims to improve treatment for traumatic brain injury 53

Feb 20, 2017: ICON Selected by the FDA to Validate Patient-Reported Outcome Endpoints for Antibacterial Drug Trials 54

Other Significant Developments 55

Oct 01, 2018: ICON announces release of ADDPLAN Neo 55

Jun 22, 2018: ICON and DIA driving Insights to Action with DIA Live 2018 56

Apr 03, 2018: ICON announces launch of Government and Public Health Solutions to support global public health 57

Nov 21, 2017: FIRECREST Pre-Screen improves sponsor visibility of patient access 58

Nov 06, 2017: ICON Reveals Voice-Assistant Applications for Clinical Trials at ISPOR Annual European Congress 59

Oct 27, 2017: ICON and ICHOM unveil the world's first global patient outcomes benchmarking platform 60

Appendix 61

Methodology 61

About GlobalData 61

Contact Us 61

Disclaimer 61


List Of Figure

List of Figures

ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ICON Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ICON Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

ICON Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

ICON Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

ICON Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

ICON Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

ICON Plc, Deals By Therapy Area, 2012 to YTD 2018 9

ICON Plc, Medical Devices Deals, 2012 to YTD 2018 10

ICON Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Icon Completes Acquisition Of Clinical Trial Services Business From Cross Country Healthcare For Up To USD 56 Million 12

Aptiv Solutions Raises USD 5.7 Million In Venture Financing 13

Inclinix Merges With PMG Research 14

Aptiv Solutions Enters Into Licensing Agreement With Tessella For FACTS, Adaptive Trial Design Software 15

ICON Raises USD350 Million in Private Placement of 3.64% Notes Due 2020 16

ICON Acquires Mapi 17

Icon Acquires Clinical Research Management 18

Icon Acquires PMG Research from Frontier Capital 19

ICON Acquires MediMedia Pharma Solutions for USD120 Million 20

Icon Completes Acquisition Of Aptiv Solutions For USD 143.5 Million 21

Icon Completes Acquisition Of BeijingWits Medical Consulting, Contract Research Organization 23

ICON Plc, Key Competitors 24

ICON Plc, Key Employees 25

ICON Plc, Subsidiaries 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

ICON Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.